Thomas Garry J MD is categorized under Family Practice Doctors in Bethlehem, PA and active since 2005.
Thomas Garry J MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Garry Thomas at the company’s single location by writing to 2045 Westgate Drive # 201, Bethlehem, Pennsylvania PA 18017 or by phoning (610) 865-1184. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Thomas Garry J MD |
| Contact Person: | Garry Thomas |
| Address: | 2045 Westgate Drive # 201, Bethlehem, Pennsylvania 18017 |
| Phone Number: | (610) 865-1184 |
| Website Address: | thomasretinal.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Thomas Garry J MD was started in 2005 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Garry Thomas for inquiries that concern Thomas Garry J MD by calling the company number (610) 865-1184, as your correspondence is most welcome. Additionally, the physical location of the single location of Thomas Garry J MD can be found at the coordinates 40.64133,-75.40786 as well as the street address 2045 Westgate Drive # 201 in Bethlehem, Pennsylvania 18017.
For its online presence, you may visit Thomas Garry J MD’s website at thomasretinal.com and engage with its social media outlets through on Twitter and on Facebook.